Beyond the Echo: Is Comprehensive Vascular Exploration Valuable in Cases of Non-Syndromic Thoracic Aortic Aneurysms or Bicuspid Aortic Valve?
Authors:
- Austin SaugstadASAustin Saugstad
- Srekar RaviSRSrekar Ravi
- George BcharahGBGeorge Bcharah
- Christine E. FirthCFChristine E. Firth
- Hend BcharahHBHend Bcharah
- Hussein Abdul NabiHNHussein Abdul Nabi
- Hoang Nhat PhamHPHoang Nhat Pham
- Ramzi IbrahimRIRamzi Ibrahim
- Sant J. KumarSKSant J. Kumar
- Mahmoud AbdelnabiMAMahmoud Abdelnabi
- Linnea M. BaudhuinLBLinnea M. Baudhuin
- Yuxiang WangYWYuxiang Wang
Open Access
- 24 April 2025
- journal article
- research article
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 12 (5) , 167
Abstract
Bicuspid aortic valve (BAV) and thoracic aortic aneurysms and dissections (TAAD) are recognized in syndromic connective tissue diseases (CTD), but most cases occur sporadically. The extent to which non-syndromic BAV or TAAD predisposes to additional arteriopathies, particularly in younger individuals, remains unclear. We retrospectively analyzed 1438 patients (mean age = 48.0, 67.7% female), excluding those with CTDs. Participants were ≤60 years old and categorized by the presence of BAV and/or TAAD. We examined co-existing arterial pathologies, including fibromuscular dysplasia, spontaneous coronary artery dissection, abdominal aortic aneurysms (AAA), mesenteric, peripheral extremity, and carotid/cerebral arteriopathies. Overall, 44.6% had either BAV or TAAD, and 27.2% had multiple arteriopathies. While vascular diseases were frequently noted, odds ratios demonstrated no significantly increased risk of extra-aortic arteriopathies in the BAV or TAAD cohorts. AAA exhibited a non-significant trend toward higher prevalence in TAAD patients. These findings support current guidelines recommending targeted imaging (transthoracic echocardiography of the aortic root and ascending aorta) over comprehensive “head-to-pelvis” screening for non-syndromic BAV or TAAD patients without additional risk factors. Ongoing genetic analyses may elucidate whether particular variants predispose to multi-site aneurysms or dissections. Consequently, targeted surveillance remains appropriate, with broader imaging reserved for patients with genetic or clinical indicators of higher risk.Keywords
This publication has 16 references indexed in Scilit:
- 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice GuidelinesCirculation, 2022
- 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice GuidelinesCirculation, 2021
- Nonsyndromic Thoracic Aortic Aneurysms and Dissections—Is Screening Possible?Seminars in Thoracic and Cardiovascular Surgery, 2019
- Epidemiology and management of thoracic aortic dissections and thoracic aortic aneurysms in Ontario, Canada: A population-based studyThe Journal of Thoracic and Cardiovascular Surgery, 2018
- The revised Ghent nosology for the Marfan syndrome: Table 1Journal of Medical Genetics, 2010
- Ehlers‐Danlos syndrome – a historical reviewBritish Journal of Haematology, 2008
- MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin IIHuman Molecular Genetics, 2007
- Familial Thoracic Aortic Aneurysms and Dissections—Incidence, Modes of Inheritance, and Phenotypic PatternsThe Annals of Thoracic Surgery, 2006
- Aortic root dilatation in young men with normally functioning bicuspid aortic valvesHeart, 1999
- Familial Patterns of Thoracic Aortic AneurysmsArchives of Surgery, 1999